ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Insulin resistance in NAFLD patients is associated with reduced adiponectin secretion by adipocytes, which is mainly manifested by adiponectin mediated signaling down-regulation of fatty acid β -oxidation (FAO), inhibition of glucose utilization and fatty acid synthesis.